Lycia Therapeutics, Inc. — Form D

Lycia Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-23. The offering totals $106.6M, of which $106.6M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-05-23
• Form: D
• Accession: 0001806540-24-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $106.6M
• Amount sold: $106.6M
• Investors: 16
• Date of first sale: 2024-04-26
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-514102

Issuer

• Name: Lycia Therapeutics, Inc.
• CIK: 0001806540
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO, CA, 94080
• Phone: (650) 392-3357

Officers, directors & promoters (21)

Other filings by this issuer (3)

More

• CIK 1806540 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search